Source:http://linkedlifedata.com/resource/pubmed/id/17665979
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2007-8-1
|
pubmed:abstractText |
Peroxisome proliferator activated receptors (PPARs) are members of the nuclear receptor superfamily acting as transcription factors. PPAR-gamma, one of the three PPAR subtypes, is expressed in many malignant and non-malignant cells and tissues. PPAR-gamma ligands influence cancer biology via both genomic as well as non-genomic events. The non-genomic action of PPAR-gamma ligands, including the activation of MAPK signaling pathways, is under intense investigation. In the presence of PPAR-gamma ligands, a rapid phosphorylation of ERK1/2 is observed in many cancer cell lines. Activated ERK1/2 elicits rapid, non-genomic cellular effects and can directly repress PPAR-gamma transcriptional activity by phosphorylation. This paper reviews the interrelation of PPAR-gamma ligands and activated ERK1/2, in relation to their antineoplastic actions in cancer cell lines, which may offer the potential for improved anticancer therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1744-7631
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1071-85
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17665979-Animals,
pubmed-meshheading:17665979-Cell Line, Tumor,
pubmed-meshheading:17665979-Growth Inhibitors,
pubmed-meshheading:17665979-Humans,
pubmed-meshheading:17665979-Ligands,
pubmed-meshheading:17665979-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:17665979-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:17665979-Neoplasms,
pubmed-meshheading:17665979-PPAR gamma,
pubmed-meshheading:17665979-Receptor Cross-Talk,
pubmed-meshheading:17665979-Signal Transduction
|
pubmed:year |
2007
|
pubmed:articleTitle |
The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines.
|
pubmed:affiliation |
National & Kapodistrian University of Athens, Department of Experimental Physiology, Medical School, Goudi-Athens, Greece.
|
pubmed:publicationType |
Journal Article,
Review
|